News and Events for Attorneys and Executives

Tag: HealthLaw

HIPAA 101: The 30-Minute Guide to Understanding Compliance

HIPAA 101: The 30-Minute Guide to Understanding Compliance

Event, June 27, 2 p.m. EDT
Compliancy Group will present a free webinar on HIPAA compliance, titled “The 30-Minute Guide to Understanding Compliance.”

Continue Reading »

Health Law: Is Your Arbitration Agreement Enforceable?

Insight
A recent decision of the Arizona Court of Appeals provides guidance for evaluation of the enforceability of arbitration agreements in the health care field, reports Snell & Wilmer in its Health Law Checkup blog.

Continue Reading »

Healthcare and the False Claims Act, 2016 Survey

Healthcare and the False Claims Act, 2016 Survey

Insight
Healthcare and the False Claims Act, 2016 Survey summarizes the important laws, regulations, pronouncements, and cases of the past year, to inform healthcare providers and healthcare attorneys on this crucial statute in the healthcare industry.

Continue Reading »

Painful Verdicts for Johnson & Johnson

Painful Verdicts for Johnson & Johnson

News
The Lanier Law Firm said these verdicts marked the second and third bellwether trials among thousands of similar lawsuits nationwide that have been consolidated in multidistrict litigation in the U.S. District Court for the Northern District of Texas.

Continue Reading »

Obamacare Repeal: 18 Million Lose Insurance, Premiums Soar: Report

Obamacare Repeal: 18 Million Lose Insurance, Premiums Soar: Report

News
NBC News is reporting that about 18 million people would lose or drop their health insurance in the first year after Obamacare is repealed, the Congressional Budget Office reported Tuesday.

Continue Reading »

Johnson & Johnson Hit With Over $1 Billion Verdict on Hip Implants

Johnson & Johnson Hit With Over $1 Billion Verdict on Hip Implants

News
The New Jersey pharmaceutical and medical device maker and its DePuy Orthopaedics subsidiary must pay damages to six California plaintiffs who say they suffered serious chronic and painful medical problems caused by the device, reports The Dallas Morning News.

Continue Reading »

U.S. Charges in Generic-Drug Probe to Be Filed by Year-End

U.S. Charges in Generic-Drug Probe to Be Filed by Year-End

News
The antitrust investigation by the Justice Department spans more than a dozen companies and about two dozen drugs, reports Bloomberg.

Continue Reading »

Alabama Law Firm Says It Has Received 26k Calls After Talcum Powder Verdicts

Alabama Law Firm Says It Has Received 26k Calls After Talcum Powder Verdicts

News
A law firm in Montgomery, Ala., says it received nearly 26,000 phone calls from people inquiring about a possible link between talcum powder and ovarian cancer after its clients won a total of $127 million in two verdicts earlier this year, reports AL.com.

Continue Reading »

Theranos Walks Away From Zika Test

Theranos Walks Away From Zika Test

News
The move is another setback for the Palo Alto, Calif., company as it tries to recover from crippling regulatory sanctions that followed revelations by The Wall Street Journal of shortcomings in Theranos’s technology and operations.

Continue Reading »

Ex-Johnson & Johnson Unit Execs Guilty of Misdemeanors, Avoid Felony Convictions

News
The jury acquitted the two defendants on felony charges of wire fraud and conspiracy, finding they did not act with intent to defraud or mislead. But the two former executives were convicted on charges of promoting a product for an unapproved use, Reuters reports.

Continue Reading »

U.S. Sues to Block Anthem-Cigna and Aetna-Humana Mergers

U.S. Sues to Block Anthem-Cigna and Aetna-Humana Mergers

News
U.S. Attorney General Loretta E. Lynch said the proposed mergers “would leave much of the multitrillion-dollar health insurance industry in the hands of three mammoth insurance companies,” reports The New York Times.

Continue Reading »

Theranos CEO Holmes Banned From Operating a Lab for 2 Years

Theranos CEO Holmes Banned From Operating a Lab for 2 Years

News
Theranos Inc.’s Chief Executive Officer Elizabeth Holmes was banned for two years from owning or operating laboratories by U.S. regulators, a major blow against the controversial blood-testing startup that’s come under scrutiny for risking patient harm with unreliable tests, reports Doni Bloomfield for Bloomberg Technology.

Continue Reading »

A Leak Wounded This Company. Fighting the Feds Finished It Off

NEWS
LabMD’s future changed one day in 2008 when the company’s general manager received a phone call from a man who claimed to be in possession of a file containing patient information, including more than 9,000 Social Security numbers, reports Bloomberg.

Continue Reading »

Blood-Testing Company Theranos Is Subject of Criminal Probe by U.S.

Blood-Testing Company Theranos Is Subject of Criminal Probe by U.S.

News
Federal prosecutors have launched a criminal investigation into whether Theranos Inc. misled investors about the state of its technology and operations, according to people familiar with the matter, The Wall Street Journal is reporting.

Continue Reading »

Abbott Wins in $1 Billion Trial Over Marketing of Stents

News
Abbott Laboratories didn’t cause medical providers to submit false payment claims to Medicare for unapproved stents, a Texas jury ruled, thwarting a whistle-blower’s lawsuit seeking as much as $1 billion, reports Bloomberg.

Continue Reading »

Executive Fired After Opposing 5,000% Drug Price Hike

News
A former vice president of the drugmaker that drew national criticism for raising the price of a parasite-fighting medication by 5,000% testified he was fired weeks after telling CEO Martin Shkreli the increase “was not justified,” reports USA Today.

Continue Reading »

Celgene Announces Settlement of REVLIMID Patent Litigation

Celgene Announces Settlement of REVLIMID Patent Litigation

NEWS
Celgene has agreed to provide Natco with a license to Celgene’s patents required to manufacture and sell an unlimited quantity of generic lenalidomide.

Continue Reading »

image_pdfimage_print
Top